$PHCI
Panamera Holdings Corp

2022 Q1 Form 10-Q Financial Statement

#000164033422000341 Filed on February 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $6.240K $2.440K $70.22K
YoY Change -75.6%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.237K $2.440K $70.22K
YoY Change 33.16% -77.27%
Operating Profit -$6.237K -$2.440K
YoY Change 33.16% -77.27%
Interest Expense $389.00 $67.00 -$300.00
YoY Change -73.3% -95.2%
% of Operating Profit
Other Income/Expense, Net -$389.00 $67.00
YoY Change -73.3% -104.8%
Pretax Income -$6.626K -$2.507K -$70.53K
YoY Change 7.9% -79.34% 605.3%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.626K -$2.507K -$70.53K
YoY Change 7.9% -79.34% 605.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$169.10 -$64.01 -$1.749K
COMMON SHARES
Basic Shares Outstanding 39.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00 $10.00 $10.00
YoY Change
Cash & Equivalents $14.00 $11.00 $10.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $10.00 $11.00 $10.00
YoY Change -93.24% -92.2% -99.55%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.00 $11.00 $10.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $10.00 $11.00 $10.00
YoY Change -93.24% -92.2% -99.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.15K $12.08K $13.51K
YoY Change 51.5% 20.8% 108.49%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $8.840K $5.480K $1.610K
YoY Change -92.63% -95.02% -98.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.98K $17.56K $15.12K
YoY Change -82.81% -86.83% -87.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $23.98K $17.56K $15.12K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $23.98K $17.56K $15.12K
YoY Change -82.81% -86.83% -87.74%
SHAREHOLDERS EQUITY
Retained Earnings -$373.1K -$366.5K -$364.0K
YoY Change 30.05% 30.53% 35.49%
Common Stock $3.921K $3.921K $3.921K
YoY Change -97.34% -97.34% -97.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$23.97K -$17.55K -$15.11K
YoY Change
Total Liabilities & Shareholders Equity $14.00 $11.00 $10.00
YoY Change -90.54% -92.2% -99.55%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$6.626K -$2.507K -$70.53K
YoY Change 7.9% -79.34% 605.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.350K -$3.874K -$83.14K
YoY Change -59.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.350K $3.875K 82.99K
YoY Change -48.33% 729.9%
NET CHANGE
Cash From Operating Activities -3.350K -$3.874K -83.14K
Cash From Investing Activities
Cash From Financing Activities 3.350K $3.875K 82.99K
Net Change In Cash 0.0000000000009095 $1.00 -150.0
YoY Change -100.05% -101.5%
FREE CASH FLOW
Cash From Operating Activities -$3.350K -$3.874K -$83.14K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39210000 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
10 USD
CY2021Q4 us-gaap Assets
Assets
11 USD
CY2021Q3 us-gaap Assets
Assets
10 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12080 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13514 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5483 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1608 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17563 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15122 USD
CY2021Q4 us-gaap Liabilities
Liabilities
17563 USD
CY2021Q3 us-gaap Liabilities
Liabilities
15122 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3921 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3921 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
345030 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
344963 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-366503 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-363996 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-17552 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15112 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10 USD
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
28 USD
CY2020Q4 us-gaap Professional Fees
ProfessionalFees
10503 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2412 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
233 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
2440 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
10736 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2440 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10736 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
67 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7500 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
1396 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
67 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1396 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2507 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-12132 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2507 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-12132 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39210000 shares
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15112 USD
CY2021Q4 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
67 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2507 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-17552 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-121095 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-12132 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-133227 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2507 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-12132 USD
CY2021Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
67 USD
CY2020Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1434 USD
CY2021Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2020Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1396 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3874 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9591 USD
CY2021Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3875 USD
CY2020Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7500 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3875 USD
CY2021Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2091 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2232 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141 USD
CY2021Q4 us-gaap Interest Paid
InterestPaid
0 USD
CY2020Q4 us-gaap Interest Paid
InterestPaid
0 USD
CY2021Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3875 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5483 USD
CY2021Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
67 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares

Files In Submission

Name View Source Status
0001640334-22-000341-index-headers.html Edgar Link pending
0001640334-22-000341-index.html Edgar Link pending
0001640334-22-000341.txt Edgar Link pending
0001640334-22-000341-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20211031.xsd Edgar Link pending
pnht-20211031_cal.xml Edgar Link unprocessable
pnht-20211031_def.xml Edgar Link unprocessable
pnht-20211031_lab.xml Edgar Link unprocessable
pnht-20211031_pre.xml Edgar Link unprocessable
pnht_10q.htm Edgar Link pending
pnht_10q_htm.xml Edgar Link completed
pnht_ex311.htm Edgar Link pending
pnht_ex312.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending